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Large doses of intravenous glucocorticoids 
given over one to two hours have been util-
ized ,for some time now to supplement chron-
ic immunosuppressive drug programs in order 
to effectively reverse acute or chronic rejec-
tion of organ homografts (1-5). Since the 
renin-angiotensin system has been implicated 
in chronic and acute renal homograft rejec-
tion (6), we have investigated the effects of 
these rapid infusions of glucosteroids on plas-
ma renin activity (PRA). 
Materials and Methods. Fifteen patients 
and 5 normal subjects were investigated. The 
patients (7) were receiving oral maintenance 
doses of prednisone, 20 to 170 mg per day, 
as listed in our previous publication (7) , 
and azathioprine. All patients and normal in-
dividuals were kept supine beginning 1 hr 
before the study. Each was given 1 g of 
prednisolone intravenously in 50 to 100 ml 
of 0.9% saline over one hour. Blood was 
drawn into sodium-EDTA containing tubes 
which were kept in ice until they were centri-
fuged at 40 and the plasma frozen. Samples 
were obtained immediately preceding and 
immediately after the prednisolone infusion 
in all subjects and in some at the midpoint. 
PRA was measured by a radioimmunoassay 
method (8). The normal range for this assay 
in the supine position is 0.20--3.62 ng angio-
tensin I/mljhr on a 113 mEq sodium diet 
and 2.13-13.8 ng/ml/hr on a 10 mEq sodi-
um diet. None of the patients or normals 
were being subjected to sodium restriction. 
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Results. Ten subjects were sampled at all 
three times (Table I). All four of the nor-
mals and 4 of the 6 patients so studied had a 
reduction of PRA at the infusion midpoint 
compared to the control level. One out of the 
4 normals and 4 of the 6 patients had reduc-
tions in PRA at the end point compared to 
the midpoint of the infusion. Three of the 4 
normals and 4 of the 6 patients demonstrated 
reductions after the infusion compared to 
before. 
In Table II are listed the PRA values for 
the individuals sampled only before and after 
the infusion. Six of the 9 patients, as well as 
the one normal, had reduced their PRA at 
the end of the infusion. 
Thus, in the entire group of subjects 
studied, all 5 normals and 11 of the 15 pa-
tients had a significant (p < .025) PRA re-
duction at either the midpoint or the end of 
the prednisolone infusion. Two of the 4 pa-
tients who did not respond demonstrated 
chronic rejection 0. M. and H. R.) and the 
2 others (S. J. and W. D.) had acute rejec-
tion. Several of the responders also had acute 
rejection. The three subjects receiving the 
largest maintenance doses of prednisolone 
(C. E. 170 mg, W. D. 120 mg, S. J. 120 mg) 
responded slightly or not at all in terms of 
reduction of PRA. 
Discussion. All but two of the homograft 
patients 0. M. and R. c., Table II) had 
higher basal PRA levels than the normal sub-
jects. This finding will be described more 
fully in a later communication. 
This study has also shown that rapid infu-
sion of large doses of prednisolone resulted in 
an acute reduction in PRA in most patients 
and all normal controls. Previous studies of 
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the effects of glucocorticoids on PRA in man 
(9, 10) were carried out with much smaller 
doses given over longer periods of time. 
Those studies showed no consistent change in 
PRA with glucocorticoid treatment. In the 
rat, however, moderate doses of glucosteroid 
have been found to reduce PRA (11). 
The mechanism of prednisolone-induced 
reduction of PRA is not well understood. 
Glucocorticoids have been shown to increase 
acutely extracellular fluid volume in dehy-
drated dogs, probably by a shift of salt and 
water from intracellular to extracellular com-
partments (12). Intravenous administration 
of glucocorticoids to normal humans induced 
an acute increase in cardiac output (13). 
These two phenomena, sudden increases in 
extracellular fluid volume and cardiac out-
put, might initiate a signal (14) for the re-
duction of renin secretion which would re-
duce the vasopressor (15) and salt-retaining 
( 16) effects of both the reduced renal func-
tion and of the angiotensin-aldosterone sys-
tem in a rejection episode. In a previous 
study from our laboratories (7), however, the 
TABLE I. Plasma Renin Activity Before, During 
and at the End of One Hour Infusion of 1 g 
Prednisolone. 
Time ·of sampling (hr) Pre % 1 
Plasma renin activity 
Sllbjeets (ng Angiotensin I/mljhr) 
Patient.s 
L.O. 23.3 15.6 0 
O.E. 10.4 8.0 13.5 
0.0. 36.2 3.5 11.5 
O.B. 29.7 36.5 23.4 
M.P. :38.0 23.0 9.7 
W.D. 5.1 26.6 15.4 
Mean 23.78 18.86 12.25 
P value compared to >.5 <.10 
baseline 
Normal 
P.M. 2.4 1.2 3.1 
P.W. 4.9 3.1 2.7 
O.A. 2.9 1.3 2.2 
G.S. 4.2 0 1.3 
Mean 3.6 ].4 2.3 
P value compared to <.05 <.2 
baseline 
TABLE II. Plasma Renin Activity Before and at 
End of One Rour Infusion of 1 g Prednisolone. 
Time of sampling 
Subjects 
Patients 
J.M. 
R.R. 
P.E. 
S.J. 
D.G. 
T.S. 
R.O. 
M.K. 
S.E. 
Mean 
p value compared 
to baseline 
Normal 
R.J. 
Pre Post 
Plasma renin activity 
(ng Angiotensin I/mljhr) 
2.3 
5.2 
19.3 
21.5 
25.2 
6.9 
1.9 
11.0 
9.6 
11.43 
1.6 
3.0 
8.1 
17.6 
36.1 
8.5 
2.3 
1.3 
6.4 
5.0 
9.81 
>.5 
1.1 
latter mechanism was not very effective be-
cause sodium clearance was increased only 
during the first hour of study. This was fol-
lowed by two hours of relatively positive so-
dium balance. 
Another salutary consequence for the re-
jecting kidney of the acute reduction in PRA 
brought about by the prednisolone infusions 
might be a reduction in the amount of in-
trarenal vasospasm as a consequence of in-
trarenal formation of angiotensin (17). 
From the point of view of therapeutic 
effect, however, it must be noted that the 
four non-responders in our group had consid-
erable increases in PRA as a result of the 
infusion, which might be detrimental. 
Summary. Large doses of intravenous glu-
cocorticoids have been used in an attempt to 
reverse homograft rejection. The intravenous 
administration of 1 g prednisolone over 1 hr 
resulted in a significant acute reduction of 
plasma renin activity in 5 normal subjects 
tested and in 11 out of 15 patients bearing 
renal homogmfts. No definite explanation for 
failure to respond nor the mechanism of this 
prednisolone effect is readily at hand. An 
acute decrease in renin activity could be salu-
tary for the chronically or acutely rejecting 
patient in that it could reduce vasopressor 
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and salt-retaining effects. However, several of 
the non-responders had an increase in renin 
activity which could have been detrimental. 
Judith Anne Smith rendered expert technical assis-
tance. 
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